Spago Nanomedical Interim Report January-June 2026
(PR-inside.com) LUND, SE / ACCESS Newswire / August 20, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) APRIL - JUNE IN BRIEF Net sales for the quarter amounted to KSEK 0 (KSEK 81) The loss for the quarter amounted to KSEK -7,331 (KSEK -6,964) Operating expenses for the quarter amounted to KSEK -8,418 (KSEK -8,291) …
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


